Annual CFF
$34.75 M
-$255.16 M-88.01%
December 31, 2023
Summary
- As of February 24, 2025, RLAY annual cash flow from financing activities is $34.75 million, with the most recent change of -$255.16 million (-88.01%) on December 31, 2023.
- During the last 3 years, RLAY annual CFF has fallen by -$391.76 million (-91.85%).
- RLAY annual CFF is now -91.85% below its all-time high of $426.51 million, reached on December 31, 2020.
Performance
RLAY Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$218.89 M
+$217.35 M+14095.14%
September 30, 2024
Summary
- As of February 24, 2025, RLAY quarterly cash flow from financing activities is $218.89 million, with the most recent change of +$217.35 million (+14095.14%) on September 30, 2024.
- Over the past year, RLAY quarterly CFF has increased by +$209.43 million (+2214.33%).
- RLAY quarterly CFF is now -48.64% below its all-time high of $426.19 million, reached on September 30, 2020.
Performance
RLAY Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$291.27 M
+$209.43 M+255.90%
September 30, 2024
Summary
- As of February 24, 2025, RLAY TTM cash flow from financing activities is $291.27 million, with the most recent change of +$209.43 million (+255.90%) on September 30, 2024.
- Over the past year, RLAY TTM CFF has increased by +$277.27 million (+1980.36%).
- RLAY TTM CFF is now -56.70% below its all-time high of $672.76 million, reached on September 30, 2022.
Performance
RLAY TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
RLAY Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -88.0% | +2214.3% | +1980.4% |
| 3 y3 years | -91.8% | +10000.0% | +6945.7% |
| 5 y5 years | -91.2% | +10000.0% | +5095.7% |
RLAY Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -91.0% | at low | -43.0% | >+9999.0% | -56.7% | +1980.4% |
| 5 y | 5-year | -91.8% | +519.9% | -48.6% | >+9999.0% | -56.7% | >+9999.0% |
| alltime | all time | -91.8% | +519.9% | -48.6% | >+9999.0% | -56.7% | >+9999.0% |
Relay Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $218.89 M(>+9900.0%) | $291.27 M(+255.9%) |
| Jun 2024 | - | $1.54 M(-96.8%) | $81.84 M(-0.7%) |
| Mar 2024 | - | $48.92 M(+123.2%) | $82.38 M(+137.0%) |
| Dec 2023 | $34.75 M(-88.0%) | $21.92 M(+131.7%) | $34.75 M(+148.2%) |
| Sep 2023 | - | $9.46 M(+354.7%) | $14.00 M(-95.2%) |
| Jun 2023 | - | $2.08 M(+60.4%) | $290.41 M(+0.0%) |
| Mar 2023 | - | $1.30 M(+11.2%) | $290.32 M(+0.1%) |
| Dec 2022 | $289.91 M(-25.3%) | $1.17 M(-99.6%) | $289.91 M(-56.9%) |
| Sep 2022 | - | $285.87 M(>+9900.0%) | $672.76 M(+73.5%) |
| Jun 2022 | - | $2.00 M(+126.0%) | $387.79 M(+0.2%) |
| Mar 2022 | - | $883.00 K(-99.8%) | $386.92 M(-0.3%) |
| Dec 2021 | $388.09 M | $384.01 M(>+9900.0%) | $388.09 M(+9287.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $902.00 K(-19.5%) | $4.13 M(-99.0%) |
| Jun 2021 | - | $1.12 M(-45.5%) | $429.43 M(+0.3%) |
| Mar 2021 | - | $2.06 M(+3569.6%) | $428.21 M(+0.4%) |
| Dec 2020 | $426.51 M(+7508.1%) | $56.00 K(-100.0%) | $426.51 M(+0.1%) |
| Sep 2020 | - | $426.19 M(<-9900.0%) | $426.23 M(>+9900.0%) |
| Jun 2020 | - | -$93.00 K(-126.5%) | $147.00 K(-83.8%) |
| Mar 2020 | - | $351.00 K(-254.6%) | $910.00 K(-83.8%) |
| Dec 2019 | $5.61 M(-98.6%) | -$227.00 K(-295.7%) | $5.61 M(-3.9%) |
| Sep 2019 | - | $116.00 K(-82.7%) | $5.83 M(+2.0%) |
| Jun 2019 | - | $670.00 K(-86.7%) | $5.72 M(+13.3%) |
| Mar 2019 | - | $5.05 M | $5.05 M |
| Dec 2018 | $394.97 M | - | - |
FAQ
- What is Relay Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Relay Therapeutics?
- What is Relay Therapeutics annual CFF year-on-year change?
- What is Relay Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Relay Therapeutics?
- What is Relay Therapeutics quarterly CFF year-on-year change?
- What is Relay Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Relay Therapeutics?
- What is Relay Therapeutics TTM CFF year-on-year change?
What is Relay Therapeutics annual cash flow from financing activities?
The current annual CFF of RLAY is $34.75 M
What is the all time high annual CFF for Relay Therapeutics?
Relay Therapeutics all-time high annual cash flow from financing activities is $426.51 M
What is Relay Therapeutics annual CFF year-on-year change?
Over the past year, RLAY annual cash flow from financing activities has changed by -$255.16 M (-88.01%)
What is Relay Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of RLAY is $218.89 M
What is the all time high quarterly CFF for Relay Therapeutics?
Relay Therapeutics all-time high quarterly cash flow from financing activities is $426.19 M
What is Relay Therapeutics quarterly CFF year-on-year change?
Over the past year, RLAY quarterly cash flow from financing activities has changed by +$209.43 M (+2214.33%)
What is Relay Therapeutics TTM cash flow from financing activities?
The current TTM CFF of RLAY is $291.27 M
What is the all time high TTM CFF for Relay Therapeutics?
Relay Therapeutics all-time high TTM cash flow from financing activities is $672.76 M
What is Relay Therapeutics TTM CFF year-on-year change?
Over the past year, RLAY TTM cash flow from financing activities has changed by +$277.27 M (+1980.36%)